Crossmark

Small-molecule allosteric inhibitors of BAX

Crossref DOI link: https://doi.org/10.1038/s41589-018-0223-0

Published Online: 2019-02-04

Published Print: 2019-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Garner, Thomas P.

Amgalan, Dulguun https://orcid.org/0000-0001-6398-3372
Reyna, Denis E.

Li, Sheng

Kitsis, Richard N. https://orcid.org/0000-0003-1395-9694
Gavathiotis, Evripidis https://orcid.org/0000-0001-6319-8331
License Information

Text and Data Mining valid from 2019-02-04
More Information

Article History

Received: 29 August 2018

Accepted: 18 December 2018

First Online: 4 February 2019

Competing interests

: E.G., R.N.K., T.P.G, and D.A. are inventors on a patent application PCT/US2018/021644 submitted by Albert Einstein College of Medicine that covers compounds, compositions and methods for BAX inhibition for the treatment of diseases and disorders.